427 related articles for article (PubMed ID: 2522347)
1. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
Robinson SP; Jordan VC
Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
4. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
Schafer JM; Lee ES; O'Regan RM; Yao K; Jordan VC
Clin Cancer Res; 2000 Nov; 6(11):4373-80. PubMed ID: 11106256
[TBL] [Abstract][Full Text] [Related]
5. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.
Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC
Breast Cancer Res Treat; 1990 Feb; 15(2):95-101. PubMed ID: 2138919
[TBL] [Abstract][Full Text] [Related]
7. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
8. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies with toremifene as an antitumor agent.
Robinson SP; Parker CJ; Jordan VC
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S9-17. PubMed ID: 2149286
[TBL] [Abstract][Full Text] [Related]
10. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
McLeskey SW; Kurebayashi J; Honig SF; Zwiebel J; Lippman ME; Dickson RB; Kern FG
Cancer Res; 1993 May; 53(9):2168-77. PubMed ID: 8481920
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes.
Anderson WA; Perotti ME; McManaway M; Lindsey S; Eckberg WR
J Submicrosc Cytol; 1984 Oct; 16(4):673-90. PubMed ID: 6438351
[TBL] [Abstract][Full Text] [Related]
13. Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice.
Iino Y; Takai Y; Ando T; Sugamata N; Maemura M; Takeo T; Ohwada S; Morishita Y
Cancer Chemother Pharmacol; 1993; 32(5):353-8. PubMed ID: 8339385
[TBL] [Abstract][Full Text] [Related]
14. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Jacobson HI; Bennett JA; Mizejewski GJ
Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
Toi M; Bicknell R; Harris AL
Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
[TBL] [Abstract][Full Text] [Related]
18. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
19. A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene.
Yue W; Zhou D; Chen S; Brodie A
Cancer Res; 1994 Oct; 54(19):5092-5. PubMed ID: 7923123
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
